ACSRX
Price
$31.10
Change
+$0.16 (+0.52%)
Updated
Jul 3 closing price
Net Assets
12.75B
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

ACSRX vs VIVAX

Header iconACSRX vs VIVAX Comparison
Open Charts ACSRX vs VIVAXBanner chart's image
Invesco Comstock R
Price$31.10
Change+$0.16 (+0.52%)
VolumeN/A
Net Assets12.75B
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
ACSRX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ACSRX vs. VIVAX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACSRX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. ACSRX (12.8B). VIVAX pays higher dividends than ACSRX: VIVAX (2.06) vs ACSRX (1.31). ACSRX was incepted earlier than VIVAX: ACSRX (23 years) vs VIVAX (33 years). ACSRX (1.06) is less costly to investors than VIVAX (0.17). ACSRX is a more actively managed with annual turnover of: 18.00 vs. VIVAX (9.00). ACSRX has a lower initial minimum investment than VIVAX: ACSRX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 11.40 vs. ACSRX (6.61). VIVAX return over 5 years is better than : 79.11 vs. ACSRX (67.20).
ACSRXVIVAXACSRX / VIVAX
Total Expense Ratio1.060.17624%
Annual Report Gross Expense Ratio1.060.17624%
Fund Existence23 years33 years-
Gain YTD8.8555.603158%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets12.8B189B7%
Annual Yield % from dividends1.312.0663%
Returns for 1 year6.6111.4058%
Returns for 3 years17.5534.3951%
Returns for 5 years67.2079.1185%
Returns for 10 years36.28114.5132%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BKMC104.380.80
+0.77%
BNY Mellon US Mid Cap Core Equity ETF
XBI85.240.45
+0.53%
SPDR® S&P Biotech ETF
DIVY26.340.10
+0.37%
Sound Equity Dividend Income ETF
XPH41.280.05
+0.12%
SPDR® S&P Pharmaceuticals ETF
LLDR45.10-0.47
-1.02%
Global X Long-Term Treasury Ladder ETF